Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs12597299 | chr16:89822364 | C/A | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs12597862 | chr16:25666094 | T/C | 2.16E-8 | 175 | 25.6 | 25.87 | 8.12 | KM Plot |
PCPG | rs12597950 | chr16:1669339 | A/G | 1.52E-11 | 173 | 24.85 | 30.93 | 4.52 | KM Plot |
PCPG | rs12598214 | chr16:89841424 | C/T | 0.000181 | 176 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs12598276 | chr16:89829196 | G/C | 0.000167 | 177 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs12598316 | chr16:89916600 | C/A | 1.11E-16 | 171 | 25.87 | 23.37 | 3.17 | KM Plot |
PCPG | rs12598737 | chr16:89920957 | A/G | 0.000185 | 172 | 25.87 | 23.37 | 36.37 | KM Plot |
PCPG | rs12599002 | chr16:89817569 | G/A | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs12599473 | chr16:89827435 | A/C | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs12599561 | chr16:89894358 | C/G | 0.000192 | 173 | 25.87 | 21.5 | 36.37 | KM Plot |
PCPG | rs12599644 | chr16:1959185 | C/T | 1.47E-5 | 173 | 25.6 | 24.1 | 13.23 | KM Plot |
PCPG | rs12599846 | chr16:89818908 | C/T | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs12600047 | chr16:89831630 | G/A | 0.000177 | 174 | 26.57 | 20.2 | 36.37 | KM Plot |
PCPG | rs12600051 | chr16:89992072 | G/T | 1.11E-16 | 171 | 25.87 | 20.28 | 3.17 | KM Plot |
PCPG | rs12600151 | chr16:89831558 | C/T | 0.000167 | 177 | 25.87 | 20.17 | 36.37 | KM Plot |